Company intelligence / Profile preview
Laboratorios Salvat
Esplugues de Llobregat, Barcelona, Spainsvt.com ↗
- Ownership
- Private
- Employees
- ~750
- Development stage
- Commercial
01
Overview
Salvat has multiple commercial products and is conducting clinical trials for new formulations. Their SVT-15473 (clobetasol ophthalmic) has completed Phase III trials in adults and is now being tested in pediatric patients. Clotrimazole (SVT-15652) for otitis externa is in pre-registration with a high likelihood of approval.
- Therapeutic areas
- OtherDermatologyOphthalmologyGastroenterology
- Modalities
- Small moleculesnanoemulsionstopical formulations
- Industry
- Biotech
02
Drug pipeline
15 assets14 more assets in the full pipeline.
Beyond the preview
Go deeper on Laboratorios Salvat.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Laboratorios Salvat.